Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 386 (OTC: $EDXC) (CSE: $GGB.C) (OTCQB: $GGBXF) (CSE: $VIBE.C) (TSXV: $KHRN.V) (OTCQB: $KHRNF)
Delta, Kelowna, BC, March 20th, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/03201EDXC-GGB-GGBXF-VIBE-KHRN-KHRNF.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few company announcements.
CBD Unlimited, Inc. (OTC: EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, announced that Daniel S. Brandwein, D.P.M., F.A.C.F.A.S., Florida board-certified foot and ankle surgeon, joined the Board of Directors.
“I am honored to serve as a board member for CBD Unlimited and will continue to promote the advancement of CBD use as part of patients’ overall health and wellness protocol,” commented Dr. Brandwein. “During an original clinical study in 2015, which was supported by CBD Unlimited, I observed and administered a CBD trial for one month through my practice. After the month-long trial, my patients were reporting relief from pain and tension. From there, I knew that I needed to be part of something special and cutting-edge in order to provide the very best care to my patients and to patients around the world.”
Daniel S. Brandwein, D.P.M., F.A.C.F.A.S. is a board-certified surgeon specializing in the field of podiatry. In addition to Dr. Brandwein’s expertise in pain management and therapeutic treatments, Dr. Brandwein has participated in clinical trials and has authored several scientific papers.
"Dr. Brandwein witnessed exceptional outcomes in early-stage clinical studies sponsored by CBD Unlimited and now his patients, as well as countless other patients, rely on CBD Unlimited’s products as part of their day-to-day health regimen,” commented Mr. Todd Davis, Chairman and Chief Executive Officer of CBD Unlimited. “We are thrilled to welcome such a distinguished and accomplished individual to our Advisory Board. Dr. Brandwein’s clinical expertise will prove to be a significant advantage in the long-term objectives of the company,” continued Davis.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) announced that Peter Horvath is stepping down as Chief Executive Officer and as a member of the Board of Directors effective today. Mr. Horvath has served as CEO of the Company since January 2019 and as a member of the Company's Board of Directors since July 2018. Randy Whitaker, the Company's current Chief Operating Officer will take over as interim Chief Executive Officer, effective immediately. Mr. Whitaker has served as the Company's Chief Operating Officer since February 2019. The vacancy on the Company's Board of Directors will be filled in due course.
Ms. Carli Posner, the Chair of the Board of Directors, said "On behalf of the Board and everyone at GGB, I would like to offer my heartfelt thanks to Peter for his significant contribution and dedication to the Company and wish Peter the best for his future endeavours."
Mr. Horvath responded, "I am humbled to have worked with such amazing professionals along this journey. Among those individuals is Randy Whitaker, whom I am pleased has been named as interim CEO. The Company will be in good hands with such a seasoned operator at the helm, and I have full confidence in Randy to lead the Company during this difficult time."
In response to the ongoing COVID-19 pandemic and in accordance with the recommendations of health professionals and other mall-based retailers, the Company has elected to temporarily close all of its mall-based cannabidiol ("CBD") kiosk shops in an effort order to protect its employees and customers from unnecessary exposure to the COVID-19 virus. In connection with this action, the Company will also suspend sales under its CBD e-commerce platform.
The Company's cannabis dispensaries, located in the Las Vegas, Nevada area, will remain open for business subject to additional pandemic-related directives from local authorities. The Company will continue to employ best practices and adhere to such directives related to its operations in light of the COVID-19 pandemic.
The Company will continue to pursue the previously announced sale of the CBD business to The BRN Group Inc. In connection therewith, the Company will continue to solicit and evaluate any potential superior offers under the go-shop rights afforded to the Company as part of that announced transaction.
Vibe Bioscience Ltd. (CSE: VIBE) announced, effective immediately, that it is offering contactless ‘Curb-side’ Pick-Up at all Vibe By California locations in addition to touchless delivery options and additional in-store safety measures.
While preparations and information continue to develop across California for COVID-19 , Vibe is working to ensure our clients and staff remain healthy. Our priority is on the safety and well-being of our employees and clients. We have always taken great pride in our clean and well-run stores, and in addition to increased frequency of cleaning for all our stores, Vibe has a dedicated team member working full time cleaning all frequently touched surfaces. We are also:
● Providing complimentary delivery service in Sacramento for those 65 years of age and older and those with a pre-existing medical condition;
● Limiting the number of clients and staff permitted inside our stores at any given time and encouraging clients to maximize their distance between our staff and other clients to reduce transmission dynamics and potential communicability;
● Encouraging clients to complete their purchases online using our website, ensuring online orders are accurate and available for immediate pick-up; and
● Obtained local and State approvals to provide compliant touchless pickup options at all locations.
Vibe continues to work closely with international and State public health authorities to monitor the situation regarding the Coronavirus. We will continue to follow the guidance of local and international health authorities to make informed decisions and provide our clients and staff with information as we continue to learn and improve our processes.
Everyone has a vital role during the management of this outbreak. We are confident that together we will overcome this challenge soon by taking the necessary protective measures and working collectively as a unified community. As this issue continues to evolve, we remain committed to supporting our clients and valued team.
For more information on our touchless delivery and curbside pick-up option, please visit www.vibebycalifornia.com.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced that the Company has received certification of Good Elaboration Practices for Magistral Preparations with Cannabis (GEP). As a result, the Company is now fully authorized to manufacture high- and low-THC magistral preparations in Colombia. The Company anticipates fulfilling its first prescriptions of full-spectrum, high CBD formulations within days. The Company anticipates that it will also be fully authorized to fulfill prescriptions and dispense psychoactive (high-THC) medical cannabis within the coming weeks, once the pharmacies are authorized by the Narcotics National Fund (FNE).
"Today is a hugely important milestone for Khiron. With this GEP certification we begin a new phase in commercializing our medical cannabis product pipeline and towards meeting our market potential. We have been preparing for this day for three years. We have the capacity, established patient network, and now full authorization to manufacture high- and low-THC magistral preparations, and to fulfill prescriptions for non-psychoactive medicinal cannabis within days," comments Alvaro Torres, Khiron CEO and director. "From day one our mission has always been to model our business on serving patient needs, and now we are delivering on that focus, targeting the millions of patients in Colombia who have the potential to benefit from medical cannabis."
Khiron has an established patient network in Colombia through its ILANS medical facilities that treat over 120,000 patients with neurological, psychiatric, respiratory, urological and orthopedic diseases, among others. ILANS patients are serviced by the Colombian health insurance system. The Company also recently opened Zerenia, a 15,000 sq. ft facility in Bogota that increases the Company's patient capacity by 75%, offering a comprehensive suite of health and medical services in alignment with insurance company partners.
Under Colombian regulations, GEP certification is a manufacturing and processing certification that is a mandatory requirement for commercializing customized medical cannabis prescriptions, known as Magistral Preparations. Commercializing customized medical cannabis prescriptions in Colombia involves a lengthy and rigorous regulatory process that has seen the Company receive licenses to cultivate high-THC and low-THC cannabis for domestic and export sales, quotas to cultivate 9.3 tons of THC cannabis, and to extract THC cannabis in Colombia. To-date, Khiron is the only company in Colombia to meet all of these strict regulatory requirements, and, with the GEP certification received today, becomes the first Company authorized to sell medical cannabis in Colombia.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
